ALB and paraplegia: Replacing the CSF with albumin- or gelatin-modified artificial CSF under physiological ICP conditions (10–15 mmHg) significantly prevented the development of paraplegia (~20% paraplegic rate, Fig. 1A, groups 4-open triangles, and 5-closed squares).